oral semaglutide obesity Wegovy approved for management by FDA on December 23, 2025 Formulation: Highβdose oral (25 mg daily) β previously only available as weekly injections. Indication: Adults with obesity (BMI β₯30) π¨ Oral Semaglutide 25 mg
Pay in 4 interest-free payments of $6.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 27 - Nov 1

























